Found "Public health policy": 989 results
Tita Jongsomjit, PhD.
Tita Jongsomjit has been working as a Research Assistant at the Health Intervention and Technology Assessment Program (HITAP) Foundation since 2024. She holds a doctoral degree in Statistics from Thammasat University and is committed to applying her expertise and skills to conduct impactful research. Her primary area of interest is health technolog
The way home: a scoping review of public health interventions to increase the utilization of home dialysis in chronic kidney disease patients
Abstract
Background
Home dialysis (HoD) remains underutilized, despite evidence showing it provides comparable mortality rates to in-center hemodialysis (ICHD) while offering advantages such as improved quality of life and lower overall costs. This scoping review comprehensively evaluates the
The use of economicevaluation for guiding the pharmaceutical reimbursement list in Thailand. (2014)
Summary
Medicines expenditure consumes a significant proportion of public health expenditure in Thailand, where Universal Health Coverage has been in place since 2002. The National List of Essential Medicines has been successfully used as a pharmaceutical benefits package for all public health plan
The use of comparative effectiveness research to inform policy decisions on the inclusion of bevacizumab for the treatment of macular diseases in Thailand’s pharmaceutical benefit package
Abstract: There is increasing impetus to use pharmaceutical interventions, ie, ranibizumab or bevacizumab, for the treatment of particular macular diseases. This paper describes the evidence and decision-making of the National List of Essential Medicines Committee that recently announced the inclusi
The Trouble With ‘Doctor Knows Best’
Doctors were told last month that we should stop doing so many screenings for prostate cancer with the prostate-specific antigen test. We learned that sigmoidoscopy is a cheaper, easier and effective alternative to colonoscopy for colon cancer screening. And a study I led turned up strong evidence t
The Thai Version of the EQ-5D-5L Health Questionnaire
Evaluating health-related quality of life has many benefits. It can beused to evaluate the results of treatment from diseases as well as monitor population health. In addition, it can also be used in various types of research such as clinical research and econo measuring generic health status. The d
The Thai population-based preference scores for EQ-5D health states
Economic evaluation can be a tool to assist policy makers in resource allocation decision making. In cost-utility analysis, health outcomes resulting from health interventions are measured using several methods, for example, Quality-Adjusted Life Year (QALY). The QALY is a single index score in which both health-related quality of life and life exp
The Suggestion for Research Management in Developing the Emergency Medical Institute of Thailand
This suggestion report aims to present how to manage and utilize the existing researches to policy and how to enhance the research capacity of the EMS agencies201-344-2553
The socio-economic impact of anti-microbial resistance in Singapore: A One Health perspective
Antimicrobial resistance (AMR) will continue to significantly impact healthcare and public health around the world. Given the complexity of AMR and the multi-dimensional nature of its aetiology and impact, a multi-sectoral and inter-disciplinary approach is required to mitigate its impact. “One Health” is an approach to designing and implementi
The role of health technology assessment evidence in decision making: the case of Human Papillomavirus vaccination
Introduction: Cervical cancer is a major cause of deaths in female in low- and middle-income countries. The disease is preventable by introducing screening tests such as Pap smears, visual inspection with acetic acid (VIA) and HPV DNA testing. Recently, the first vaccine against human papillomavirus (HPV) was introduced to the health care market t
10 / Page